Processing chemicals, such as antibiotics, vitamins, and other ingredients, are used to separate foods from the moisture and fats that keep them from sticking together.
The chemicals are often sprayed directly on the food, so the products look and taste identical to what they’re supposed to be.
It can take months or even years for a product to get through the process.
But that’s not how it works for the millions of people who have had the process removed from their foods.
According to an investigation by the New York Times, a number of studies have shown that people who use CBE are at higher risk for developing heart disease and cancer, as well as for having a weakened immune system and being more prone to chronic illness.
These findings have spurred lawmakers to try to get food processors to stop the process, and the FDA recently approved a new rule that bans the use of CBE in food.
The FDA’s new rule also requires food processors that use CBEs to conduct an “audit” of their processes, and it sets a deadline for companies to comply.
If they don’t comply by April 31, the FDA will have the power to fine them up to $5 million, according to a copy of the rule obtained by the Times.
The FDA also has the authority to ban the sale of certain types of products that have CBEs in them.
“This rule is a great example of what can be done when food is truly the food,” says Sarah L. Shaffer, the director of the Center for Food Safety at Tufts University, who spoke with the Times by phone about the FDA’s move.
“The FDA has been working with industry to come up with a comprehensive set of rules that address what’s really happening in food processing.”
The FDA says that the rule is intended to protect consumers from foodborne illness.
The agency says that it has not received any reports of illness or death related to food processed with CBEs.
The rules also require food processors in the United States to inform consumers of the risks associated with the process and give them the option of switching to non-CBEs.
The move comes as the FDA continues to look at the potential for a new antibiotic, azithromycin, to be added to the US food supply.
This antibiotic is used to treat the common cold and other respiratory illnesses, and its use has risen dramatically in recent years.
FDA officials said earlier this year that they are reviewing the possibility of making the drug available in the US.
In a statement to the Times, the Food and Drug Administration said that it had not received evidence that people could get heart disease from eating food that is treated with CBE, nor had it been determined that people exposed to the process would be more likely to develop a disease.
It also noted that there have been no deaths or serious health issues associated with CBEx use.
According a statement on the FDA website, CBEs are “a safe and efficient means of processing foods for human consumption.”